Results 101 to 110 of about 344,829 (184)

Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis

open access: yes, 2013
Improvement to the immunogenicity of DNA vaccines was evaluated in a Mycobacterium tuberculosis (MTB) infection mouse model examining the combined effects of nonlytic Fc-fused IL-7 DNA (IL-7-nFc) and Flt3-ligand fused Mtb32 (F-Mtb32) DNA.
조상래
core   +1 more source

Nutritional Applications of Green Magnesium Nanoparticles as Functional Feed Additives in Broiler Diets: Towards Sustainable Poultry Production

open access: yesVeterinary Medicine and Science, Volume 12, Issue 5, September 2026.
Nanoparticles, including green magnesium nanoparticles, facilitate passage through cellular membranes in animals and interact efficiently with biological systems, improving their functional activity. The results indicated that BNMg supplementation enhances performance, antioxidant efficacy, immune system status, blood mineral concentrations, digestive ...
Fayiz M. Reda   +7 more
wiley   +1 more source

Economic evaluation of human papillomavirus vaccination in the United Kingdom. [PDF]

open access: yes, 2008
OBJECTIVE: To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. DESIGN: Economic evaluation. SETTING: UK. Population Schoolgirls aged 12 or older.
Choi, Yoon Hong   +2 more
core   +1 more source

Immunological Cross‐Reactivity and Neutralizing Efficacy of Antivenom Against Five Medically Important Iranian Viper Venoms

open access: yesVeterinary Medicine and Science, Volume 12, Issue 5, September 2026.
Investigating Iranian viper venoms reveals compositional and antigenic diversity impacting antivenom efficacy. The study highlights the need to incorporate both broadly cross‐reactive and specifically under‐represented venoms into immunization mixtures to optimize paraspecific protection strategies.
Sedigheh Khamehchian   +4 more
wiley   +1 more source

Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands

open access: yesBMC Medicine
Background Most European countries offer human papillomavirus (HPV) vaccination through organised immunisation programmes, but the choice of vaccine varies.
Birgit Sollie   +2 more
doaj   +1 more source

Immunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia

open access: yesJournal of Immunology Research, 2017
Pseudomonas aeruginosa lung infections present a major challenge to healthcare systems worldwide because they are commonly associated with high morbidity and mortality.
Bahador Behrouz   +6 more
doaj   +1 more source

Vaccine Coverage and Vaccination Delays in Children With Chronic Illness: A French Multicentre Point‐Prevalence Survey

open access: yes
Acta Paediatrica, EarlyView.
F. Dubos   +18 more
wiley   +1 more source

Integrated Engineering of CAR‐T Cells for Solid Tumours

open access: yesCell Proliferation, Volume 59, Issue 9, September 2026.
Solid tumours pose multifactorial barriers including antigen heterogeneity, immunosuppressive microenvironment, and poor T‐cell trafficking, limiting CAR‐T efficacy compared to hematologic malignancies. Integrated engineering strategies are essential, combining logic‐gated receptors for precision, metabolic‐epigenetic reprogramming for resilience, and ...
Chao Yang   +5 more
wiley   +1 more source

Adjuvants : an essential component of neisseria vaccines [PDF]

open access: yes, 2009
Adjuvants may be classified into delivery systems and immune potentiator or modulator molecules based on their mechanism of action. Neisseria vaccines containing traditional adjuvants such as aluminium salts have existed for long time, but meningitis ...
Acevedo, R.   +8 more
core   +2 more sources

Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg

open access: yesCancer Epidemiology, 2019
In Luxembourg, the human papillomavirus (HPV) vaccination program introduced in 2008, provided either bivalent (BV) or quadrivalent (QV) vaccines to girls aged 12-17 years. Here, we estimate the effectiveness of BV and QV vaccines combined and separately in reducing type-specific HPV prevalence eight years after the introduction of the vaccination ...
Ardashel Latsuzbaia   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy